Anke Biotechnology: Exclusive agency product recombinant human follicle stimulating hormone-CTP fusion protein injection approved for market.

Anke Biology announced that the product Reconstituted Human Follicle Stimulating Hormone-CTP Fusion Protein Injection, exclusively represented by the company in mainland China and Hong Kong, Macau and Taiwan regions, has been approved for listing by the National Medical Products Administration. This product is the first domestically approved long-acting recombinant human follicle stimulating hormone.